237 related articles for article (PubMed ID: 20693973)
21. Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant.
Kulik GI
Drugs Exp Clin Res; 1998; 24(5-6):277-80. PubMed ID: 10190087
[TBL] [Abstract][Full Text] [Related]
22. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells.
Pal S; Choudhuri T; Chattopadhyay S; Bhattacharya A; Datta GK; Das T; Sa G
Biochem Biophys Res Commun; 2001 Nov; 288(3):658-65. PubMed ID: 11676493
[TBL] [Abstract][Full Text] [Related]
24. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
Boyko VN; Zholus RB
Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of fungal growth product (6MFA), assessed therapeutically against Ehrlich's ascites tumor in Swiss mice.
Mall SA; Zaidi SI; Hussain MM; Singh KP; Mathur N; Gupta BM
J Biol Regul Homeost Agents; 1991; 5(2):45-51. PubMed ID: 1897382
[TBL] [Abstract][Full Text] [Related]
26. [14C-riboflavin metabolism in mice with Ehrlich's ascitic tumor].
Trebukhina RV; Mikhal'tsevich GN
Vopr Pitan; 1978; (4):49-55. PubMed ID: 685222
[TBL] [Abstract][Full Text] [Related]
27. Study of interactions between Listeria monocytogenes and experimental tumors.
Krybus J; Bueno MA; Feder D; Andrade Júnior AF; Cabral M; Novak A; Martins MC
Rev Paul Med; 1992; 110(3):102-7. PubMed ID: 1340994
[TBL] [Abstract][Full Text] [Related]
28. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
29. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of the cytostatic effects of Oliphen and Ukrain.
Voltchek I; Kamyshentsev M; Lavinsky Y; Nowicky J; Medvedev Y; Litvinchuk L
J Chemother; 1996 Apr; 8(2):144-6. PubMed ID: 8708746
[TBL] [Abstract][Full Text] [Related]
31. Ehrlich's ascites fluid adsorbed over protein A containing Staphylococcus aureus Cowan I produces inhibition of tumor growth.
Verma AS; Dwivedi PD; Mishra A; Ray PK
Immunopharmacol Immunotoxicol; 1999 Feb; 21(1):89-108. PubMed ID: 10084332
[TBL] [Abstract][Full Text] [Related]
32. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
Bonmassar E; Melan F; Testorelli C
Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
[No Abstract] [Full Text] [Related]
33. [On the effect of Rantarin FM and its combination with Thio-TEPA on the transplantability and growth of Ehrlich's tumor].
Iaremenko KV; Shishenkova NM
Vopr Onkol; 1968; 14(2):95-6. PubMed ID: 4971178
[No Abstract] [Full Text] [Related]
34. [The effect of ascitic fluid globulins on the growth of leukemia P388/DOX and Ehrlich's carcinoma in mice].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Nov; 114(11):518-9. PubMed ID: 1290828
[TBL] [Abstract][Full Text] [Related]
35. [Effect of substances of bacterial origin on Ehrlich's carcinoma].
Aïzenman BIu; Shvaiger MO; Mandrik TP; Bredikhina AM; Orishchik LF; Kolesova OA; Mishenkova OL; Halkina TO; Zakharova IIa; Rashba OIa; Laushnik HM; Preobrazhenska NIu
Mikrobiol Zh; 1965; 27(6):61-7. PubMed ID: 5869042
[No Abstract] [Full Text] [Related]
36. [Effect of colchamine on Ehrlich ascitic carcinoma cells showing synchronized cell division].
Volkov IN
Biull Eksp Biol Med; 1978 Feb; 85(2):195-7. PubMed ID: 204377
[TBL] [Abstract][Full Text] [Related]
37. [Morphological changes of the cells of Ehrlich's experimental ascites carcinoma in the course of immunological lysis].
Chibowski D
Ann Univ Mariae Curie Sklodowska Med; 1964; 19():465-78. PubMed ID: 4159442
[No Abstract] [Full Text] [Related]
38. Effect of six-month treatment with Ukrain on early osteoporosis induced by ovariectomy in rats. Part I: Preliminary studies of bone parameters.
Jagiełło-Wojtowicz E; Kleinrok Z; Nowicky JW; Jabłonski M; Gorzelak M; Chodkowska A; Feldo M; Matuszek B
Drugs Exp Clin Res; 1996; 22(3-5):173-6. PubMed ID: 8899324
[TBL] [Abstract][Full Text] [Related]
39. Screening of the cytotoxic action of fungus filtrates on Ehrlich's ascites carcinoma, utilizing 14 C-labelled precursors.
Fuska J; Miko M; Nemec P; Drobnica L
Neoplasma; 1971; 18(6):631-6. PubMed ID: 5160902
[No Abstract] [Full Text] [Related]
40. Estimation of direct influence of Ukrain preparation on influenza viruses and the bacteria E. coli and S. aureus.
Ciebiada I; Korczak E; Nowicky JW; Denys A
Drugs Exp Clin Res; 1996; 22(3-5):219-23. PubMed ID: 8899335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
